CLINICAL_TRIALS
trial_result
· 2022-09-27
Clinical Trial Update: Hyper-CVAD With Liposomal Vincristine in Acute Lymphoblastic Leukemia [Phase 2]
Summary
Phase 2 trial update for Hyper-CVAD with liposomal vincristine in acute lymphoblastic leukemia is completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2022-09-27